title: Rupatadine: pharmacological profile and its use in the treatment of allergic rhinitis.
abstract: Rupatadine is a once-daily, non-sedating, selective and long-acting new drug with a strong antagonist activity towards both histamine H1 receptors and platelet-activating factor receptors. The use of rupatadine is indicated in adult and adolescent patients (>12 years of age) suffering from intermittent and persistent allergic rhinitis. In the treatment of these conditions, rupatadine is at least as effective as ebastine, cetirizine, loratadine and desloratadine. Avery good safety profile of rupatadine has been evidenced in various studies, including a long-term (1-year) safety study. Rupatadine does not present drug-drug interactions with azithromycin, fluoxetine and lorazepam, but should not be administered concomitantly with known CYP3A4 inhibitors.
authors.affiliation: PSMI, Gannavaram, Vijayawada, A.P. India.
authors.forename: M
authors.initials: M
authors.lastname: Sudhakara Rao
authors.forename: D
authors.initials: D
authors.lastname: Dwarakanatha Reddy
authors.forename: P S N
authors.initials: PS
authors.lastname: Murthy
keywords: antihistamine; platelet-activating factor; rhinitis; rupatadine